Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Continuous Capture and Continuous Recovery - Novel Ideas for Product Recovery.. Kerstin Lange, Andrew Falconbridge at Alvotech and Earl Pineda Sr. Manager, Upstream Field Applications EU/APAC from Repligen Alvotech developed an intensified fed-batch process using a cell retention device for the production of a complex fusion protein. The process uses the... 2 years ago | 89 mins From Early Stage to Late Stage Development: How to Characterize a Perfusion-base Perrine Rouel, Janssen Pharmaceutical Companies of Johnson & Johnson and Tom Jeffery, Sartorius Stedim Biotech Full Title: From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD? The biopharmaceut... 4 years ago | 58 mins Can the New generation of perfusion technology compete or replace the convention Ankur Bhatnagar & John Bonham-Carter Recently, there has been a renewed interest in the field of continuous processing. Some key factors driving this interest are – availability of better... 5 years ago | 76 mins Effect of Cell Culture Process Change from Fed-batch to Continuous on... Ru Zang, Associate Director at Mersana Therapeutics and John Bonham Carter,Project Line Lead at Repligen EFFECT OF CELL CULTURE PROCESS CHANGE FROM FED-BATCH TO CONTINUOUS ON PRODUCTIVITY AND PRODUCT QUALITY Integrated continuous bioprocessing has attrac... 4 years ago | 76 mins CONTINUOUS MANUFACTURING OF BIOLOGICS: A JOURNEY FROM CONCEPT TO REALITY Himanshu Gadgil at Enzene Biosciences Ltd and Ganesh Kumar, at Sartorius Full Title: Opportunities and Challenges in Developing a Fully-Connected Continuous Manufacturing Process for Biologics Insights through case studies... 2 years ago | 113 mins Fully continuous biosimilar manufacturing framework: A case study Samir Varma, Head of Manufacturing, Enzene Biosciences and Lotta Molander, Global Product Manager, GE Healthcare Biologics manufacturing has traditionally been in fed batch mode for the last 2 decades. During the early stages of biologics manufacturing, lower cel... 5 years ago | 68 mins Next Generation Bioprocess Facility Design - A Case Study From Samsung Biologics Ken Green, Ph.D, Science and Technology at Samsung Biologics. John Bonham-Carter. Product Line Leader, Repligen A case study be presented describing initiatives and bioprocessing approaches to maximize capacity utilization within a new large scale (12x 15kL) dru... 2 years ago | 97 mins The Race for More Cells - Progress and Challenges in Maximizing Cell Densities Amit K Sharma Scientific progress in the cell and gene therapy field will accelerate clinical cell therapy programs in the coming years. As cell therapy trials adva... 3 years ago | 59 mins
